From healthy donors to B-ALL patients, the signaling network and related ligand–receptor interactions, including LGALS9-P4HB, LGAL9-HAVCR2, and CD58-CD2, showed significantly higher communication probability in B cell–C2 NK cell interaction in B-ALL (Figure 4C). Here, LGALS9 is linked to precursor B-cell acute lymphoblastic leukemia.